These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5232509)

  • 1. Studies on anti-tumor immunity. I. Homologous immunity against Ehrlich ascites tumor (acquired type of immunity against tumor).
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Mar; 26(12):1598-608. PubMed ID: 5232509
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages.
    Yasuhira K
    Acta Tuberc Jpn; 1966 Dec; 16(2):78-84. PubMed ID: 5984181
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Ehrlich ascites tumor growth by nucleoprotein. II. In vivo fate of the tumor cells.
    Bradshaw LJ; Webb DR
    J Natl Cancer Inst; 1969 Sep; 43(3):527-32. PubMed ID: 4980604
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on anti-tumor immunity. II. Studies on inhibitory effect of heterologous spleen cells on the growth of Ehrlich ascites tumor.
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Mar; 26(12):1609-16. PubMed ID: 5232510
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on transplantation immunity of Ehrlich ascites tumor and methylcholanthrene-induced tumor in mice, with special reference to local immunity of lymph nodes draining the site of sensitization.
    Kitano M; Okada Y
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):1-17. PubMed ID: 5678190
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune response against apparently host-compatible transplantable tumors.
    Manson LA; Goldstein L; Thorn R; Palmer J
    Transplant Proc; 1975 Jun; 7(2):161-4. PubMed ID: 1129841
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of gibberelic acid on the resistance of mice to subcutaneously transplanted Ehrlich ascites tumor].
    Schwartz E
    Biologia (Bratisl); 1967; 22(11):839-44. PubMed ID: 6062276
    [No Abstract]   [Full Text] [Related]  

  • 9. [Establishment of immunity against transplantation tumor by administration of gelatin and its derivatives in mice].
    Enoki Y
    Igaku To Seibutsugaku; 1971 Feb; 82(2):81-3. PubMed ID: 5165290
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
    Sur P; Roy DK
    Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
    Janik P; Dabrowski M; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
    Sethi KK; Brandis H
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
    Okubo S
    Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nonspecific suppressive effect of Ehrlich tumor ascitic fluid on transplantation immunity].
    Belokhvostov AS; Zelenkova NK
    Biull Eksp Biol Med; 1978 Oct; 86(10):474-6. PubMed ID: 361103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimentally acquired resistance to tumor transplantation and the rejection of homologous skin transplantation in mice].
    Enoki Y
    Igaku To Seibutsugaku; 1967 Mar; 74(3):185-6. PubMed ID: 4861830
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour immunity with treated ascites cells.
    Das A; Roy DK
    Indian J Exp Biol; 1980 Jun; 18(6):635-6. PubMed ID: 7439947
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
    Novikov DK
    Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.